Your search returned 9 results.

Results
	1.	Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target. [electronic resource] by Lepak, A Marchillo, K VanHecker, J Andes, D Producer: 20160906 In: Antimicrobial agents and chemotherapy vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice. [electronic resource] by Lepak, A Marchillo, K VanHecker, J Azie, N Andes, D Producer: 20160929 In: Antimicrobial agents and chemotherapy vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A simple approach for estimating gene expression in Candida albicans directly from a systemic infection site. [electronic resource] by Andes, D Lepak, A Pitula, A Marchillo, K Clark, J Producer: 20051011 In: The Journal of infectious diseases vol. 192 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. [electronic resource] by Lepak, A Nett, J Lincoln, L Marchillo, K Andes, D Producer: 20060609 In: Antimicrobial agents and chemotherapy vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	In vivo fluconazole pharmacodynamics and resistance development in a previously susceptible Candida albicans population examined by microbiologic and transcriptional profiling. [electronic resource] by Andes, D Lepak, A Nett, J Lincoln, L Marchillo, K Producer: 20060830 In: Antimicrobial agents and chemotherapy vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. [electronic resource] by Andes, D Forrest, A Lepak, A Nett, J Marchillo, K Lincoln, L Producer: 20060830 In: Antimicrobial agents and chemotherapy vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. [electronic resource] by Andes, D Diekema, D J Pfaller, M A Bohrmuller, J Marchillo, K Lepak, A Producer: 20100914 In: Antimicrobial agents and chemotherapy vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target. [electronic resource] by Lepak, A J Reda, A Marchillo, K Van Hecker, J Craig, W A Andes, D Producer: 20150520 In: Antimicrobial agents and chemotherapy vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus. [electronic resource] by Lepak, A J Seiler, P Surivet, J P Ritz, D Kohl, C Andes, D R Producer: 20171002 In: Antimicrobial agents and chemotherapy vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)